These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Troglitazone inhibits histone deacetylase activity in breast cancer cells. Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029 [TBL] [Abstract][Full Text] [Related]
4. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3. Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene. Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170 [TBL] [Abstract][Full Text] [Related]
6. Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease. Jin H; Kanthasamy A; Harischandra DS; Kondru N; Ghosh A; Panicker N; Anantharam V; Rana A; Kanthasamy AG J Biol Chem; 2014 Dec; 289(50):34743-67. PubMed ID: 25342743 [TBL] [Abstract][Full Text] [Related]
7. Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats. Seok YM; Lee HA; Park KM; Hwangbo MH; Kim IK Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):799-808. PubMed ID: 27106211 [TBL] [Abstract][Full Text] [Related]
8. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes. Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic Regulation of Dopamine Transporter mRNA Expression in Human Neuroblastoma Cells. Green AL; Hossain MM; Tee SC; Zarbl H; Guo GL; Richardson JR Neurochem Res; 2015 Jul; 40(7):1372-8. PubMed ID: 25963949 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival. Obier N; Uhlemann CF; Müller AM Cytotherapy; 2010 Nov; 12(7):899-908. PubMed ID: 20210674 [TBL] [Abstract][Full Text] [Related]
12. Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression. Jacobs FM; van Erp S; van der Linden AJ; von Oerthel L; Burbach JP; Smidt MP Development; 2009 Feb; 136(4):531-40. PubMed ID: 19144721 [TBL] [Abstract][Full Text] [Related]
13. The role of histone acetylation in SMN gene expression. Kernochan LE; Russo ML; Woodling NS; Huynh TN; Avila AM; Fischbeck KH; Sumner CJ Hum Mol Genet; 2005 May; 14(9):1171-82. PubMed ID: 15772088 [TBL] [Abstract][Full Text] [Related]
15. Re-Cloning the N27 Dopamine Cell Line to Improve a Cell Culture Model of Parkinson's Disease. Gao L; Zhou W; Symmes B; Freed CR PLoS One; 2016; 11(8):e0160847. PubMed ID: 27512998 [TBL] [Abstract][Full Text] [Related]
16. Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications. He XB; Yi SH; Rhee YH; Kim H; Han YM; Lee SH; Lee H; Park CH; Lee YS; Richardson E; Kim BW; Lee SH Stem Cells; 2011 Nov; 29(11):1861-73. PubMed ID: 21922608 [TBL] [Abstract][Full Text] [Related]
17. Regulation of intestinal serotonin transporter expression via epigenetic mechanisms: role of HDAC2. Gill RK; Kumar A; Malhotra P; Maher D; Singh V; Dudeja PK; Alrefai W; Saksena S Am J Physiol Cell Physiol; 2013 Feb; 304(4):C334-41. PubMed ID: 23195070 [TBL] [Abstract][Full Text] [Related]
18. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells. Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA. Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide screening for target regions of histone deacetylases in cardiomyocytes. Kaneda R; Ueno S; Yamashita Y; Choi YL; Koinuma K; Takada S; Wada T; Shimada K; Mano H Circ Res; 2005 Aug; 97(3):210-8. PubMed ID: 16002748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]